We addressed the question of whether 0,11-dihydro-5H-dibenzo[a,d]cyclo
hepten-5,10-imine (MK-801) and DL-(E)-2-amino-4-methyl-5-phosphono-3-p
entenoic acid (CGP37849), a non-competitive and a competitive N-methyl
-D-aspartate (NMDA) receptor antagonist, respectively, are able to blo
ck morphine-induced conditioned place preference (CPP). MK-801 alone (
0.1 mg/kg) produced neither a place preference nor a place aversion, b
ut was able to completely block morphine-induced CPP. CGP37849 alone (
10 mg/kg) produced a small but significant CPP, and was able to signif
icantly attenuate morphine-induced CPP. These results cannot be due to
simple additive effects of drug actions, but suggest that NMDA recept
ors play a complex role in the development of morphine CPP.